ITCI vs. VOO

In the year-to-date period, ITCI achieves a 57.89% return, which is significantly higher than VOO's -5.69% return. Over the past 10 years, ITCI has outperformed VOO with an annualized return of 20.12%, while VOO has yielded a comparatively lower 12.13% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Intra-Cellular Therapies, Inc. (ITCI) and Vanguard S&P 500 ETF (VOO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ITCI Sharpe Ratio is 1.72, which is higher than the VOO Sharpe Ratio of 0.55. The chart below compares the historical Sharpe Ratios of ITCI and VOO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

ITCI has not paid dividends to shareholders, while VOO's dividend yield for the trailing twelve months is around 1.38%.

The maximum ITCI drawdown since its inception was -87.64%, which is greater than VOO's maximum drawdown of -33.99%. Use the drawdown chart below to compare losses from any high point for ITCI and VOO. For additional features, visit the drawdowns tool.

The current volatility for Intra-Cellular Therapies, Inc. (ITCI) is 0.10%, while Vanguard S&P 500 ETF (VOO) has a volatility of 13.96%. This indicates that ITCI experiences smaller price fluctuations and is considered to be less risky than VOO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.